Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mills

Showing results (981-990 of 1,298) with videos related to

Pageof 130
Sort By:
Cancer Research|October 22, 2020
Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 SignalingDeepak Parashar, Bindu Nair, Anjali Geethadevi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2011
Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancerAna M Gonzalez-Angulo, Kirsten M Timms, Shuying Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2017
A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type TumorsKurt W Evans, Erkan Yuca, Argun Akcakanat, et al.
Cancer Research Communications|January 5, 2026
Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer TypesYa-Mei Hu, Faming Zhao, Julie N Graff, et al.
Journal of Cellular Biochemistry|July 20, 2004
Lysophosphatidic acid production and action: validated targets in cancer?Makiko Umezu-Goto, Janos Tanyi, John Lahad, et al.
EMBO Reports|June 17, 2018
The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancerJane Antony, Elisa Zanini, Zoe Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colonRebecca T Marquez, Keith A Baggerly, Andrea P Patterson, et al.
Oncogene|June 14, 2011
Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signalingY Lu, M Muller, D Smith, et al.
The Journal of Clinical Investigation|April 26, 2014
Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearanceRachel A Davidowitz, Laura M Selfors, Marcin P Iwanicki, et al.
Molecular Oncology|June 6, 2015
PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patientsShannon N Westin, Zhenlin Ju, Russell R Broaddus, et al.
Pageof 130

Showing results (981-990 of 1,298) with videos related to

Sort By:
Pageof 130
Cancer Research|October 22, 2020
Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 SignalingDeepak Parashar, Bindu Nair, Anjali Geethadevi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2011
Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancerAna M Gonzalez-Angulo, Kirsten M Timms, Shuying Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2017
A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type TumorsKurt W Evans, Erkan Yuca, Argun Akcakanat, et al.
Cancer Research Communications|January 5, 2026
Elevated Tumor-Associated Androgen Receptor Activity Correlates with Poor Immune Infiltration and Immunotherapy Response across Cancer TypesYa-Mei Hu, Faming Zhao, Julie N Graff, et al.
Journal of Cellular Biochemistry|July 20, 2004
Lysophosphatidic acid production and action: validated targets in cancer?Makiko Umezu-Goto, Janos Tanyi, John Lahad, et al.
EMBO Reports|June 17, 2018
The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancerJane Antony, Elisa Zanini, Zoe Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colonRebecca T Marquez, Keith A Baggerly, Andrea P Patterson, et al.
Oncogene|June 14, 2011
Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signalingY Lu, M Muller, D Smith, et al.
The Journal of Clinical Investigation|April 26, 2014
Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearanceRachel A Davidowitz, Laura M Selfors, Marcin P Iwanicki, et al.
Molecular Oncology|June 6, 2015
PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patientsShannon N Westin, Zhenlin Ju, Russell R Broaddus, et al.
Pageof 130